Lin, Nancy U.
Dana-Farber Cancer Institute,
United States
2024 Rank: 29536
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Immunology
Rank in SubField 1: 1324 out of 334837 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 29536 | 29953 |
| Total Cites | 21692 | 24316 |
| H-index | 70 | 75 |
| Hm-index | 18 | 19 |
| Number of Single Authored Papers | 13 | 13 |
| Total Cites to Single Authored Papers | 118 | 130 |
| Number of Single+First Authored Papers | 50 | 50 |
| Total Cites to Single+First Authored Papers | 4776 | 5371 |
| Number of Single+First+Last Authored Papers | 106 | 106 |
| Total Cites to Single+First+Last Authored Papers | 6378 | 7187 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 16384 | 17594 |
| Ratio of Total Citations to Distinct Citing Papers | 1.32 | 1.38 |
| Self-Citation Percentage |
10.79%
|
|
Lin, Nancy U.
Dana-Farber Cancer Institute,
United States
2022 Rank: 40190
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Neurology & Neurosurgery
Rank in SubField 1: 1800 out of 293195 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 40190 | 42206 |
| Total Cites | 13408 | 15163 |
| H-index | 55 | 59 |
| Hm-index | 15 | 16 |
| Number of Single Authored Papers | 11 | 11 |
| Total Cites to Single Authored Papers | 100 | 110 |
| Number of Single+First Authored Papers | 47 | 47 |
| Total Cites to Single+First Authored Papers | 3716 | 4191 |
| Number of Single+First+Last Authored Papers | 95 | 95 |
| Total Cites to Single+First+Last Authored Papers | 4801 | 5430 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 10232 | 11064 |
| Ratio of Total Citations to Distinct Citing Papers | 1.31 | 1.37 |
| Self-Citation Percentage |
11.57%
|
|
Lin, Nancy U.
Dana-Farber Cancer Institute,
United States
2021 Rank: 42447
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Neurology & Neurosurgery
Rank in SubField 1: 1890 out of 271773 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 42447 | 42890 |
| Total Cites | 11938 | 13522 |
| H-index | 52 | 57 |
| Hm-index | 15 | 15 |
| Number of Single Authored Papers | 11 | 11 |
| Total Cites to Single Authored Papers | 99 | 109 |
| Number of Single+First Authored Papers | 46 | 46 |
| Total Cites to Single+First Authored Papers | 3522 | 3978 |
| Number of Single+First+Last Authored Papers | 86 | 86 |
| Total Cites to Single+First+Last Authored Papers | 4498 | 5099 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 9114 | 9872 |
| Ratio of Total Citations to Distinct Citing Papers | 1.31 | 1.37 |
| Self-Citation Percentage |
11.71%
|
|
Related Profiles
Featured Profiles
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.